IMARC Group’s latest research report, titled “Protein Expression Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” The global protein expression market reached a value of US$ 2.25 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.34 Billion by 2027, exhibiting a CAGR of 10.70% during 2022-2027. Protein expression is a biotechnological process of generating specific proteins, typically attained by manipulating gene expression in an organism to express large amounts of a recombinant gene. It is increasingly vital as a pharmaceutical production mechanism for biological therapeutics and finds significant application in research, industrial and therapeutics, and others. Continual improvements in innovations, such as mass spectrometry, advancements in molecular genetics, and manufacturing techniques, are providing a boost to the market.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/protein-expression-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by product, application and end user.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Protein Expression Market
- Strategies of major players and product offerings
The global market is primarily driven by rising cases of illnesses, such as cancer, cardiovascular disease, and genetic disorders. In line with this, increasing investments in protein-based research activities is positively influencing the market growth. Furthermore, due to the incredible effectiveness of protein therapies, there is a low risk of adverse effects associated with protein therapeutics, thus catalyzing the market expansion. Apart from this, the growing demand for protein biologics and the introduction of microfluidics are acting as other growth-inducing factors. Moreover, biotechnology-based organizations are creating lucrative growth opportunities for the protein expression market by developing novel therapeutics with minimal side effects. Besides this, the widespread adoption of biotechnology as well as genetic engineering in the pharmaceutical industry and medical science is creating a positive outlook for the market.
Key Players Included in Global Protein Expression Market Research Report:
- Agilent Technologies Inc.
- Becton Dickinson and Company
- Bioneer Corporation
- Bio-Rad Laboratories Inc.
- Lonza Group AG, Merck KGaA
- New England Biolabs
- Promega Corporation
- Qiagen N.V.
- Sino Biological Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Explore Full report with TOC and List of Figures:https://www.imarcgroup.com/protein-expression-market
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Key Market Segmentation:
Breakup by Product:
- Reagents and Kits
- Cell-free Expression
- Bacterial Expression
- Yeast Expression
- Algal Expression
- Insect Expression
- Mammalian Expression
Breakup by Application:
Breakup by End User:
- Academic Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations (CROs)
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
TOC for the Protein Expression Market Research Report:
- Scope and Methodology
- Executive Summary
- Global Protein Expression Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800